| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 10,540 | 10,620 | 10:09 | |
| 10,540 | 10,620 | 10:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Pihlajalinna Oyj Bottom Line Falls In Q2 | 1 | RTTNews | ||
| 23.07. | Pihlajalinna Oyj: Pihlajalinna Half Year Financial Report 1 January-30 June 2026: Healthcare Services profitability strengthened. Changes in outsourcing agreements had the expected downward impact on profitability | 172 | GlobeNewswire (Europe) | Pihlajalinna Plc Half Year Financial Report 23 July at 8:00 a.m. EEST
Pihlajalinna Half Year Financial Report 1 January-30 June 2026: Healthcare Services profitability strengthened. Changes... ► Artikel lesen | |
| 22.07. | Pihlajalinna Oyj: Inside information, profit warning: Pihlajalinna lowers its guidance for 2026 | 214 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 22 July 2026 at 4:45 p.m. EEST
Inside information, profit warning: Pihlajalinna lowers its guidance for 2026
Pihlajalinna lowers its revenue guidance... ► Artikel lesen | |
| 28.04. | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2026: Revenue declined as expected due to expiry of outsourcing agreements, margin remained at the previous year's level | 223 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 28 April 2026 at 8:00 a.m. EEST
Pihlajalinna Interim Report 1 January-31 March 2026
Revenue declined as expected due to expiry of outsourcing agreements... ► Artikel lesen | |
| PIHLAJALINNA Aktie jetzt für 0€ handeln | |||||
| 01.04. | Dividendenbekanntmachungen (01.04.2026) | 9.518 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECOM US00766T1007 0,31 USD 0,2683 EUR AIR PRODUCTS & CHEMICALS INC US0091581068 1,81 USD 1,5666 EUR ARB CORPORATION LIMITED AU000000ARB5 0... ► Artikel lesen | |
| 31.03. | Pihlajalinna Oyj: Pihlajalinna revises its financial reporting structure and provides comparative segment information for 2025 | 307 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 31 March 2026 at 5:00 p.m. EEST
Pihlajalinna revises its financial reporting structure and provides comparative segment information for 2025
Pihlajalinna... ► Artikel lesen | |
| 31.03. | Pihlajalinna Oyj: Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc | 359 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 31 March 2026 at 2:00 p.m. EEST
Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc
The... ► Artikel lesen | |
| 12.02. | Pihlajalinna Oyj: Change in Pihlajalinna's Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer | 335 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 12 February 2026 at 8:30 a.m. EET
Change in Pihlajalinna's Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer
Heikki... ► Artikel lesen | |
| 12.02. | Pihlajalinna Oyj: Pihlajalinna to launch long-term share-based incentive plan performance period 2026-2028 | 277 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 12 February 2026 at 8:15 a.m. EET
Pihlajalinna to launch long-term share-based incentive plan performance period 2026-2028
The Board of Directors of Pihlajalinna... ► Artikel lesen | |
| 12.02. | Pihlajalinna Oyj: Pihlajalinna Financial Statements Release 1 January-31 December 2025: Strong profitability development continued in 2025 | 369 | GlobeNewswire (Europe) | Pihlajalinna Plc Financial Statements Release 12 February 2026 at 8:00 a.m. EET
Pihlajalinna Financial Statements Release 1 January-31 December 2025
Strong profitability development continued... ► Artikel lesen | |
| 31.10.25 | Pihlajalinna Oyj: Inside Information: Pihlajalinna's new operating model and appointment of the Management Team | 348 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 31 October 2025 at 8:30 a.m. EET
Inside Information: Pihlajalinna's new operating model and appointment of the Management Team
Pihlajalinna Plc's new operating... ► Artikel lesen | |
| 31.10.25 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-30 September 2025: Pihlajalinna's profitability improved despite weaker demand compared to comparison period | 325 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 31 October 2025 at 8:00 a.m. EET
Pihlajalinna Interim Report 1 January-30 September 2025
Pihlajalinna's profitability improved despite... ► Artikel lesen | |
| 30.10.25 | Pihlajalinna Oyj: Inside information, profit warning: Pihlajalinna's profitability outlook unchanged, but revenue decreases in 2025 | 379 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 30 October 2025 at 4:15 p.m. EET
Inside information, profit warning: Pihlajalinna's profitability outlook unchanged, but revenue decreases... ► Artikel lesen | |
| 27.10.25 | Pihlajalinna Oyj: Inside Information: Pihlajalinna has been selected as the service provider for the complete outsourcing of services in Northern Pirkanmaa | 319 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 27 October 2025 at 11:15 a.m. EET
Inside Information: Pihlajalinna has been selected as the service provider for the complete outsourcing... ► Artikel lesen | |
| 25.09.25 | Pihlajalinna Oyj: Inside Information: Pihlajalinna plans to reform its operating model to ensure development and growth in line with the strategy | 311 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 25 September 2025 at 1:00 p.m. EET
Inside Information: Pihlajalinna plans to reform its operating model to ensure development and growth in line with the... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EUROFINS SCIENTIFIC | 69,88 | +0,17 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 10th August to 14th August 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| ICON | 147,15 | +1,87 % | ICON PLC - 6-K, Report of foreign issuer | ||
| HEARTFLOW | 45,230 | 0,00 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| PROFUSA | 26,810 | +491,83 % | Profusa, Inc.: Profusa Announces 1-for-4 Reverse Stock Split | BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,51 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,660 | 0,00 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BETA BIONICS | 19,000 | -0,11 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,215 | 0,00 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| LIFESTANCE HEALTH GROUP | 12,355 | -0,04 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 87,98 | -0,01 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PROGYNY | 25,710 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| SANARA MEDTECH | 34,150 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| GENEDX | 76,37 | +0,04 % | GeneDx launches online exome testing for pediatric patients | ||
| FRESENIUS MEDICAL CARE | 40,550 | -0,42 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,330 | +0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |